VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3277
ETF rank
ยฃ10.16 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ15.39
Share price
1.27%
Change (1 day)
7.03%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of May 2026: 0.35%